By-health Co Ltd
SZSE:300146

Watchlist Manager
By-health Co Ltd Logo
By-health Co Ltd
SZSE:300146
Watchlist
Price: 15.2 CNY -0.98% Market Closed
Updated: May 25, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

15.1B
+5%
Assets
Growth Rates:
1 Year
+15%
3 Years
-
5 Years
-
7 Years
-
10 Years
-
2.9B
+36%
Liabilities
Growth Rates:
1 Year
+19%
3 Years
-
5 Years
-
7 Years
-
10 Years
-
12.2B
-0.6%
Equity
Growth Rates:
1 Year
+14%
3 Years
-
5 Years
-
7 Years
-
10 Years
-

Balance Sheet Decomposition
By-health Co Ltd

15.1B
Assets
2.9B
Liabilities
15.1B
Assets
2.9B
Liabilities
Current Assets 8.3B
Cash & Short-Term Investments 6.4B
Receivables 597.4m
Other Current Assets 1.3B
Non-Current Assets 6.8B
Long-Term Investments 2.1B
PP&E 2.5B
Intangibles 1.9B
Other Non-Current Assets 286.7m
Current Liabilities 2.5B
Accounts Payable 426.6m
Accrued Liabilities 358.9m
Other Current Liabilities 1.7B
Non-Current Liabilities 468m
Long-Term Debt 161.5m
Other Non-Current Liabilities 306.5m

Balance Sheet
By-health Co Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
1 537
1 444
2 016
2 650
1 802
1 822
1 826
2 902
2 961
3 327
Cash
1 537
1 444
2 016
2 647
1 802
1 822
1 826
2 900
2 959
3 324
Cash Equivalents
0
0
0
3
0
0
0
2
2
4
Short-Term Investments
0
1 230
650
300
865
690
41
240
2 670
3 111
Total Receivables
103
119
166
268
360
228
391
413
478
597
Accounts Receivables
43
52
54
154
221
114
164
290
330
249
Other Receivables
60
67
112
114
139
114
227
123
148
348
Inventory
229
309
339
422
671
742
873
833
899
989
Other Current Assets
43
33
58
419
397
326
1 719
2 951
297
288
Total Current Assets
1 912
3 135
3 230
4 058
4 096
3 808
4 850
7 339
7 304
8 313
PP&E Net
579
697
721
670
720
950
984
1 181
1 252
2 493
PP&E Gross
579
697
721
670
720
950
984
1 181
1 252
2 493
Accumulated Depreciation
99
141
195
266
340
416
497
607
724
763
Intangible Assets
104
172
226
224
1 599
902
948
823
764
702
Goodwill
0
0
0
0
2 166
1 184
1 216
1 120
1 142
1 175
Long-Term Investments
49
866
1 129
1 078
1 086
1 284
1 329
1 375
2 434
2 128
Other Long-Term Assets
57
35
23
83
124
204
315
1 128
261
287
Other Assets
0
0
0
0
2 166
1 184
1 216
1 120
1 142
1 175
Total Assets
2 701
N/A
4 905
+82%
5 328
+9%
6 114
+15%
9 790
+60%
8 331
-15%
9 640
+16%
12 966
+35%
13 158
+1%
15 098
+15%
Liabilities
Accounts Payable
67
79
185
275
339
339
350
408
367
427
Accrued Liabilities
39
90
65
173
270
139
255
247
267
359
Short-Term Debt
0
0
5
0
158
43
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
0
209
103
33
20
13
Other Current Liabilities
137
166
351
464
724
1 027
1 531
1 384
1 468
1 665
Total Current Liabilities
243
335
606
913
1 491
1 757
2 238
2 071
2 122
2 463
Long-Term Debt
0
0
0
0
893
308
144
41
4
161
Deferred Income Tax
6
6
9
11
407
224
218
221
190
153
Minority Interest
0
8
24
31
1 296
61
9
43
63
75
Other Liabilities
4
11
10
58
112
111
99
96
85
78
Total Liabilities
253
N/A
343
+36%
648
+89%
1 013
+56%
4 199
+315%
2 339
-44%
2 707
+16%
2 472
-9%
2 464
0%
2 931
+19%
Equity
Common Stock
658
728
1 470
1 469
1 469
1 582
1 581
1 700
1 700
1 701
Retained Earnings
916
1 188
1 286
1 670
2 188
1 158
2 120
2 803
2 985
4 418
Additional Paid In Capital
874
2 639
1 994
2 032
2 023
3 213
3 197
6 174
6 113
6 121
Unrealized Security Profit/Loss
0
0
0
0
0
0
0
56
58
73
Treasury Stock
0
0
91
81
51
27
0
0
0
18
Other Equity
0
7
20
10
37
65
36
128
48
19
Total Equity
2 448
N/A
4 562
+86%
4 680
+3%
5 101
+9%
5 592
+10%
5 992
+7%
6 934
+16%
10 494
+51%
10 693
+2%
12 167
+14%
Total Liabilities & Equity
2 701
N/A
4 905
+82%
5 328
+9%
6 114
+15%
9 790
+60%
8 331
-15%
9 640
+16%
12 966
+35%
13 158
+1%
15 098
+15%
Shares Outstanding
Common Shares Outstanding
1 316
1 456
1 456
1 456
1 456
1 569
1 581
1 700
1 700
1 701

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 140,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.